Hasil Pencarian (1)
Etrolizumab
DB12189
biotech | CAS: 1044758-60-2
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is typified by a chronic gastrointestinal inflammatory microenvironment, driven in part by the excessive infiltration and retention of intestinal-homing lymphocytes.[A244564, …
Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal
+10
Target Protein:
Integrin beta-7
Waktu ParuhEtrolizumab adminis…
Vol. DistribusiModelling of etroli…
KlirensEtrolizumab has a m…
Genetik
-